Sharepoint Solutions
PRODUCTS
-
Code and approve clinical trial data from any device and keep your safety and efficacy data clean, consistent, and ready for analysis.
-
Scale up your viral vector or gene therapy manufacturing cost-effectively with HEKima Adherent, a QuickStart Media designed to simplify customization and accelerate development and production.
-
Whenever possible, Mueller tailors product certification to match specific job requirements, including part numbers, job identification, and funding agency requirements. We have developed this process working closely with the Environmental Protection Agency (EPA) who was very early in clarifying definitions and requirements for Iron & Steel Products, Construction Materials, and other Manufactured Products.
-
By combining purpose-built polymers and lipids, animal-origin-free reagents seamlessly blend into the AAV manufacturing process during transfection to dramatically increase AAV titers.
-
Scientific knowledge to strategize viable and efficient drug and device development pathways to achieve successful outcomes.
WHITE PAPERS AND CASE STUDIES
-
Gene Therapy For Mitochondrial Disease: A Guide To Emerging Regulation
Learn how the FDA's expedited programs, along with the efforts of innovative companies, are paving the way for the development of effective gene therapies to address primary mitochondrial diseases.
-
Newport News, VA Deploys 130,000 Mueller AMI Meters
Eight years ago, Newport News started having discussions about moving away from reading their mechanical, manually read meters every other month to go to monthly billing. Knowing they did not have adequate staffing to handle that task, the department decided to outsource its meter reading responsibilities to a third party.
-
Annex 1: Sterile Fill/Finish For Early Phase Clinical Supplies
Meeting stringent requirements for sterile fill/finish operations hinges on robust contamination control strategies, advanced isolator technology, and rigorous integrity testing to ensure patient safety.
-
GSK And Medable Discuss The Next Phase Of DCTs
GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.
-
Streamlining Early-Phase Oncology Study Start-Up In Today's Clinical Environment
Explore the significance of targeted therapies and adaptive trial designs that prioritize patient-specific characteristics.
-
Development Of A Non-Standard Protein Therapeutic
Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.
-
Rescuing Data Integrity: A Swift Transition And Quality Transformation
Uncover how this collaboration supported timely progress toward key study milestones, enabling smoother execution and more dependable output across data management and statistical activities.
-
A Digital Solution Embeds Quality Into Cellular Therapeutics Production
Discover how Dendreon cut review and release time by nearly 50% while maintaining a 99% right-first-time rate, which boosts collaboration, visibility, and operational efficiency across teams.
-
Response To FDA Black Box Warning
The FDA has launched an investigation into the risk of T-cell malignancies following CAR-T cell immunotherapies. Review the key points of this announcement concerning the CGT research community.
-
Digitalizing Batch Records In Pharmaceutical Production
Pharma manufacturing embraces cutting-edge automation, yet outdated paper-based documentation hinders efficiency and delays batch releases. See how digital solutions can transform compliance.
-
The Role Of A Consulting Firm In The IND Process
Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.
-
Patient-Focused Data Capture For Cancer Research
In a field where innovation is constant and patient experience is pivotal, oncology demands eCOA solutions designed to balance scientific rigor with human realities.
NEWS
-
PolyPeptide Strengthens Global Peptide Production With Modular Facility Design Approach9/24/2025
PolyPeptide Group AG (SIX: PPGN), a specialized, global CDMO for peptide-based active pharmaceutical ingredients, today announced the successful delivery and installation of pre-built modules at its Malmö, Sweden facility. This marks a key milestone in the company’s modular expansion project at the site, which aims to double its solid-phase peptide synthesis (SPPS) capacity.
-
Latvian Scientists Create A Tool For More Efficient Public Procurement Evaluation1/10/2026
Much of public procurement evaluation consists of manual work by experts and specialists. This is time-consuming, since it involves comparing extensive documentation, evaluating compliance with regulatory requirements—like whether there are competition-restricting criteria—and other factors.
-
Egetis Therapeutics Initiates New Drug Application In The USA For Emcitate (Tiratricol) For MCT8 Deficiency12/19/2025
Egetis Therapeutics AB (publ) (“Egetis” or the “Company”), today announced that the Company has initiated a rolling New Drug Application (NDA) submission to the U.S. Food and Drug Administration (FDA) for Emcitate (tiratricol), its investigational drug for the treatment of MCT8 deficiency.
-
New Method To Pinpoint Soil Erosion Could Help Protect Waterways9/3/2025
Cranfield University experts have developed a new method to precisely identify soil erosion hotspots along waterways, allowing for pre-emptive mitigation measures to be put in place that protect land and water systems.
-
Cleanfarms And TNRD Launch Agricultural Plastics Recycling Pilot Program10/8/2025
Cleanfarms and the Thompson-Nicola Regional District (TNRD) are launching a new pilot program to recycle bale wrap and silage bags and covers.